NM_000400.4:c.183+2T>A
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The NM_000400.4(ERCC2):c.183+2T>A variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000366 in 1,613,062 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000400.4 splice_donor, intron
Scores
Clinical Significance
Conservation
Publications
- cerebrooculofacioskeletal syndrome 2Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
- trichothiodystrophy 1, photosensitiveInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Illumina, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp
- xeroderma pigmentosum group DInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Laboratory for Molecular Medicine, ClinGen, Labcorp Genetics (formerly Invitae), G2P
- sarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- COFS syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- trichothiodystrophyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- xeroderma pigmentosumInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- xeroderma pigmentosum-Cockayne syndrome complexInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000331 AC: 5AN: 151214Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000795 AC: 2AN: 251490 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 0.0000369 AC: 54AN: 1461848Hom.: 0 Cov.: 33 AF XY: 0.0000426 AC XY: 31AN XY: 727234 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000331 AC: 5AN: 151214Hom.: 0 Cov.: 32 AF XY: 0.0000407 AC XY: 3AN XY: 73774 show subpopulations
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Canonical splice site variant predicted to result in an in-frame loss of the adjacent exon in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25525159, 7585650) -
This sequence change affects a donor splice site in intron 3 of the ERCC2 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in ERCC2 are known to be pathogenic (PMID: 9238033, 11335038, 19085937, 19934020). This variant is present in population databases (rs201127596, gnomAD 0.007%). Disruption of this splice site has been observed in individual(s) with xeroderma pigmentosum (PMID: 7585650). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 329529). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
Cerebrooculofacioskeletal syndrome 2 Pathogenic:1
- -
Xeroderma pigmentosum, group D Pathogenic:1
ACMG classification criteria: PVS1 strong, PM2 moderated -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at